Underwater cables are a vital piece of the AI buildout and internet — investment is booming
Over 95% of international data and voice traffic travels through subsea telecom cables. Tech giants Meta, Google, Amazon and Microsoft are investing for AI.
Bank of America says Domino’s Pizza is among the most likely M&A candidates
U.S. M&A deals are tracking for the best year for dealmaking activity since 2021, Bank of America said.
Carl Icahn returns to a familiar sector — auto repair — as he builds a 15% stake in Monro
Icahn has a long history in the automotive parts and services industry, so this investment could play out in several different ways.
These stocks are the most oversold in the selloff and could be due for a bounce
A disappointing week for the market isn’t bad news for all stocks, as several beaten-down names in the S&P 500, such as Fiserv, could soon be due for a rally,
Warren Buffett’s cash fortress Berkshire closes gap with S&P 500 as AI worries depress Wall Street
Berkshire Hathaway’s B shares and A shares moved 4.5% higher this week after a strong earnings report last weekend.
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Pfizer said it would pay $86.25 per share in cash, a premium of 3.69% to Metsera’s Friday close.
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
EV maker Rivian said it was giving its CEO a revised pay package worth as much as $4.6 billion over the next decade modeled after Tesla’s Elon Musk pay plan.
Buy the weakness in stocks like Tesla and Palantir as bull market has more room to run, investor says
Investors can buy the dip on some key tech stocks after this week’s market losses, according to Eddie Ghabour, Key Advisors Wealth Management managing partner.
Palantir CEO Karp twice slams short sellers as stock suffers worst week since April
Palantir CEO Alex Karp twice confronted short sellers this week as the company’s shares suffered a double-digit drop.
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.